Retromer Opposes Opioid-Induced Downregulation of the Mu Opioid Receptor

Area of Science:

• Cell Biology
• Neuroscience
• Pharmacology

Background:

• The mu opioid receptor (MOR) is central to opioid analgesia but subject to downregulation.
• Lysosomal trafficking of MOR leads to reduced signaling, while plasma membrane recycling preserves function.
• The C-terminal LENL motif mediates MOR recycling, but its mechanism is unclear.

Purpose of the Study:

• To elucidate the molecular mechanisms by which the LENL motif facilitates MOR recycling.
• To identify genes controlling MOR expression and downregulation.
• To determine if LENL is a novel recycling motif and its role in preventing MOR downregulation.

Main Methods:

• Functional genomics approach using a comparative genome-wide screen.
• Identification of genes influencing opioid receptor expression and downregulation.
• Experimental validation of the LENL motif's interaction with the Retromer complex.

Main Results:

• A genome-wide screen identified 146 genes affecting MOR regulation, including Retromer complex subunits.
• The LENL motif was identified as a novel Retromer recycling motif.
• LENL is necessary, sufficient, and conserved for MOR access to the Retromer pathway, protecting it from downregulation by opioids like fentanyl and methadone.

Conclusions:

• The LENL motif is a novel Retromer recycling signal that dictates MOR trafficking.
• This mechanism protects MOR from agonist-induced downregulation, preserving signaling function.
• Understanding this pathway offers insights into managing opioid efficacy and side effects.